Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut

President Joe Biden frequently cites insulin prices as he promotes a $35 price cap for Americans with diabetes who are on Medicare. Roughly 8.4 million people use insulin, and more than 1 million have Type 1 diabetes and could die without regular access to the medication. The White House says nearly 4 million older people qualify for the new lower price, which Biden says compares with up to $400 monthly before. But many benefiting from the price cap were already paying far less and others were already Biden supporters. So that raises questions about how whether the issue can be as effective politically as the president believes.